Orilissa
Active substance: elagolix
TABLET, FILM COATED · ELAGOLIX SODIUM 150 mg/1
United StatesActive
Marketing holder: AbbVie Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ELAGOLIX SODIUM · 150 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1209a-bc30-765d-b488-ffa989a7cde6,01a1209c-c66f-77ea-bed7-87dfbcdf9433;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0074-0038
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0074-0038 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0074-0038 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0074-0038 · Verified 2026-10-09 · open in source